Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

AnaptysBio, Inc. (ANAB)

NASDAQ

$55.00

$+0.34

(+0.63%)

Pre-Market

AnaptysBio, Inc. (ANAB) Live Price Chart

Last updated: ⁦2026-09-16 09:45:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

AnaptysBio, Inc. (ANAB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $55.00, with a market capitalisation of $1.60B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $17.11 to $73.30. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.60B
Open	$54.66
Day's High	$134.00
Day's Low	$10.00
Previous Close	$54.68
Volume	171.00
Average Volume	588.17K
P/E Ratio	--
52-Week High	$73.30
52-Week Low	$17.11
Dividend Yield	--
Earnings Date	--

AnaptysBio, Inc. (ANAB) Pre-Market Stock Price

AnaptysBio, Inc. (ANAB) is trading at $55.00 in pre-market trading as of 2026-09-16 09:19:00, up 0.58% ($0.32) from the previous close of $54.68

Pre-market trading shows how investors are pricing ANAB before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

AnaptysBio, Inc. (ANAB) 7-Day Stock Price Change

Over the past seven days, AnaptysBio, Inc. (ANAB) moved from $56.80 to $55.00, representing a decline of 3.17% ($1.80).

The stock traded between $53.22 and $58.77 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 545.52 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ANAB 52-Week Price Position

Position in Range: 67.4%

52W Low$17.11

52W High$73.30

ANAB is currently trading at $55.00, placing it 67.4% of the way from its 52-week low of $17.11 to its 52-week high of $73.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is AnaptysBio, Inc. (ANAB)?

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

AnaptysBio, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	104
Exchange	NASDAQ
Company Website	https://www.anaptysbio.com

How to Buy AnaptysBio, Inc. (ANAB) Stock on MEXC

Eligible investors can buy real shares of AnaptysBio, Inc. (ANAB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ANAB and Place Your Order

Open the RealStocks trading page and search for ANAB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is AnaptysBio, Inc. (ANAB) stock price today?

AnaptysBio, Inc. (ANAB) is currently trading at $ 55.00, up 0.58% ($0.32) from the previous close of $ 54.68. Intraday prices update in real time during regular trading hours.

2.Is ANAB stock going up or down today?

As of 2026-09-16 09:19:00, ANAB is trading at $ 55.00, up 0.58% ($0.32) from its previous close of $ 54.68. The stock has traded between $ 10.00 and $ 134.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is ANAB pre-market price?

As of 2026-09-16 09:19:00, ANAB is trading at $ 55.00 in pre-market trading, up 0.58% ($0.32) from the previous close of $ 54.68. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ANAB after-hours price?

As of 2026-09-16 09:19:00, ANAB is trading at $ 54.66 in after-hours trading, down 0.05% ($0.02) from the regular-session close of $ 54.68. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ANAB stock trading now?

ANAB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ANAB sit relative to its 52-week high and low?

Over the past 52 weeks, ANAB has traded between a low of $ 17.11 and a high of $ 73.30. At $ 55.00, the stock is positioned 67.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is AnaptysBio, Inc. in?

AnaptysBio, Inc. (ANAB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is AnaptysBio, Inc.'s market capitalisation and where is it listed?

AnaptysBio, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1.60B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ANAB valued in terms of P/E ratio and EPS?

ANAB trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.90. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does AnaptysBio, Inc. pay a dividend?

AnaptysBio, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.